"Grey zone" of vasoreactivity during acute vasodilator testing in patients with pulmonary hypertension

"Grey zone" of vasoreactivity during acute vasodilator testing in patients with pulmonary hypertension

Aim - to analyze functional status and hemodynamic changes in patients who demonstrate vasoreactivity but doesn’t reach the criteria of "positive respond" ("grey zone") and to compare this data with "responders" and "true non-responders". Material and methods....

Full description

Bibliographic Details
Main Authors:	O V Sagaydak, N M Danilov, Yu G Matchin, T V Martynyuk, I E Chazova
Format:	Article
Language:	Russian
Published:	IP Morozov P.V. 2016-06-01
Series:	Системные гипертензии
Subjects:	pulmonary hypertension "grey zone" acute vasoreactivity test
Online Access:	https://syst-hypertension.ru/2075-082X/article/viewFile/29146/pdf

Similar Items

"Grey zone" of vasoreactivity during acute vasodilator testing in patients with pulmonary hypertension
by: Sagaydak О.V., et al.
Published: (2016-06-01)

Parameters of acute vasoreactivity testing after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension
by: Sergey Y. Yarovoy, et al.
Published: (2020-10-01)

Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension
by: Qi-Xia Xu, et al.
Published: (2017-01-01)

Vasoreactive Pulmonary Arterial Hypertension Manifesting With Misleading Epileptic Seizure: Diagnostic and Treatment Pitfalls
by: Nesrine Farhat, et al.
Published: (2019-07-01)

Type 1 neurofibromatosis complicated by pulmonary arterial hypertension: a case report
by: Murathan Küçük, et al.
Published: (2017-07-01)

Right heart catheterization procedures in patients with suspicion of pulmonary hypertension – experiences of a tertiary center
by: Maciej Grymuza, et al.
Published: (2017-11-01)

RETROSPECTIVE EFFICACY ANALYSIS OF ACUTE VASOREACTIVE TEST AS A CRITERIA FOR SURGERY IN CHILDREN WITH INBORN LEFT-TO-RIGHT BLOOD SHUNTING AND PULMONARY ARTERIAL HYPERTENSION
by: A. Mullen, et al.
Published: (2018-08-01)

Self-reported physician practices in pulmonary arterial hypertension: Diagnosis, assessment, and referral
by: Susan Polanco-Briceno, et al.
Published: (2016-04-01)

On the possibility to increase sensitivity of diagnostic tests for fixed pulmonary hypertension in heart transplant candidates
by: M. A. Bortsova, et al.
Published: (2019-07-01)

Iloprost for acute tests in patients with pulmonary arterial hypertension
by: E A Belyatko, et al.
Published: (2012-12-01)

Investigation of ischemic and demyelinating lesions by cerebral vasoreactivity based on transcranial Doppler sonography: a comparative study
by: Zoghi A, et al.
Published: (2018-09-01)

Role of the gap junctions in the contractile response to agonists in pulmonary artery from two rat models of pulmonary hypertension
by: Dahan Diana, et al.
Published: (2011-03-01)

Antecubital vein access for balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: safe new approach
by: Nikolay M. Danilov, et al.
Published: (2019-03-01)

Slow gait speed – an indicator of lower cerebral vasoreactivity in type 2 diabetes mellitus
by: Azizah J Jor'dan, et al.
Published: (2014-06-01)

Age-, Gender-, and in Vivo Different Doses of Isoproterenol Modify in Vitro Aortic Vasoreactivity and Circulating VCAM-1
by: Betzabé Nieto-Lima, et al.
Published: (2018-01-01)

Long-term outcomes after percutaneous transluminal pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
by: Madina B Karabasheva, et al.
Published: (2019-12-01)

Hybrid approach for treating patient with chronic thromboembolic pulmonary hypertension and extrinsic compression of left main coronary artery
by: Nikolay M. Danilov, et al.
Published: (2019-12-01)

Balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension
by: N M Danilov, et al.
Published: (2019-04-01)

Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry
by: I E Chazova, et al.
Published: (2019-01-01)

Dynamics of ECG indicators in patients with chronic thromboembolic pulmonary hypertension after transluminal pulmonary balloon angioplasty
by: Madina B Karabasheva, et al.
Published: (2019-06-01)

The development of a screening questionnaire to improve the early detection of pulmonary arterial hypertension
by: Z S Valieva, et al.
Published: (2014-12-01)

Cerebral Vasoreactivity Evaluated by Transcranial Color Doppler and Breath-Holding Test in Patients after SARS-CoV-2 Infection
by: Marino Marcic, et al.
Published: (2021-05-01)

Comparison of levosimendan, NO, and inhaled iloprost for pulmonary hypertension reversibility assessment in heart transplant candidates
by: Marta Tavares‐Silva, et al.
Published: (2021-04-01)

Grey zones of welfare
by: Ida Harboe Knudsen
Published: (2015-01-01)

New horizons for the use of the second generation of endothelin receptor antagonist macitentan in patients with pulmonary hypertension
by: T V Martynyuk, et al.
Published: (2018-04-01)

Oxygen-sensitivity and Pulmonary Selectivity of Vasodilators as Potential Drugs for Pulmonary Hypertension
by: Daniel Morales-Cano, et al.
Published: (2021-01-01)

Balloon angioplasty as an alternative to thromboendarterectomy for proximal pulmonary artery obstruction in a patient with chronic thromboembolic pulmonary hypertension: a case report
by: N M Danilov, et al.
Published: (2017-03-01)

New horizons for the use of the second generation of endothelin receptor antagonist macitentan in patients with pulmonary hypertension
by: T.V. Martynyuk, et al.
Published: (2018-04-01)

Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry
by: I E Chazova, et al.
Published: (2019-09-01)

Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 2)
by: I E Chazova, et al.
Published: (2016-10-01)

Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 1)
by: I E Chazova, et al.
Published: (2016-09-01)

Bosentan use in pulmonary arterial hypertension: Russian and foreign experience
by: Z S Valieva, et al.
Published: (2017-08-01)

The validation of the questionnaire for the early detection of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
by: Z S Valieva, et al.
Published: (2016-03-01)

Modern view on the place of riociguat in the treatment of pulmonary hypertension
by: Z S Valieva, et al.
Published: (2018-04-01)

Arterial pulmonary hypertension in noncardiac intensive care unit
by: Mykola V Tsapenko, et al.
Published: (2008-10-01)

Quality of life in patients with idiopathic pulmonary hypertension: the first experience of trimetazidine
by: E G Kuznetsova, et al.
Published: (2017-06-01)

The validation of the questionnaire for the early detection of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
by: Valieva Z.S., et al.
Published: (2016-01-01)

Influence of demographic characteristics on the clinical course and results of therapy in patients with precapillary pulmonary hypertension
by: Irina N. Taran, et al.
Published: (2021-03-01)

Problematic aspects of pulmonary hypertension due to left heart disease: focus on combined postcapillary and precapillary pulmonary hypertension
by: A. M. Aleevskaya, et al.
Published: (2020-10-01)

Balloon angioplasty as an alternative to thromboendarterectomy for proximal pulmonary artery obstruction in a patient with chronic thromboembolic pulmonary hypertension: a case report
by: Danilov N.M., et al.
Published: (2017-02-01)